entity

blood brain barrier

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about blood brain barrier: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

10Connections
0Hypotheses
1Analyses
2Outgoing
8Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (2)

TargetRelationTypeStr
Crisprinhibitsdrug0.80
treatment resistanceactivatesprocess0.70

Incoming (8)

SourceRelationTypeStr
32110860crossespaper0.90
34113233limits diffusion of CAR T cells acrosspaper0.90
ambroxolassociated_withdrug0.90
MNPs@FMNassociated_withdrug0.85
Cytokinesassociated_withprotein0.85

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

What is the therapeutic window between GCS inhibition efficacy and systemic toxi

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The debate identified systemic toxicity as a major concern for glucosylceramide

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

Related Research

Hypotheses and analyses mentioning blood brain barrier in their description or question text

No additional research found